2002
DOI: 10.1177/009286150203600127
|View full text |Cite
|
Sign up to set email alerts
|

Patient-Reported Outcomes: The Example of Health-Related Quality of Life—a European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory Process

Abstract: The added value for assessing the health-related quality of life (HRQOL) in chronic conditions is now well documented for evaluation of treatment eflectiveness in clinical trials and as a criterion for licensing new medications and in policy decisions. However; European standards still need to be developed for the measurement and reporting of HRQOL in clinical trials. This is one of the objectives of the European Regulatory Issues on Quality of Life Assessment (ERIQA) Working Group. This document reviews the m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
270
0
17

Year Published

2004
2004
2023
2023

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 340 publications
(296 citation statements)
references
References 86 publications
3
270
0
17
Order By: Relevance
“…The psychometric validation followed recommendations from published guidelines. [27][28][29]31,32 In February 2001, an observation study was conducted with 98 respondents who reported a clinical diagnosis of ED in the past year (49 were treated with sildenafil at least once, 49 were not treated) 4. I felt that sex could be spontaneous.…”
Section: Validationmentioning
confidence: 99%
“…The psychometric validation followed recommendations from published guidelines. [27][28][29]31,32 In February 2001, an observation study was conducted with 98 respondents who reported a clinical diagnosis of ED in the past year (49 were treated with sildenafil at least once, 49 were not treated) 4. I felt that sex could be spontaneous.…”
Section: Validationmentioning
confidence: 99%
“…They are now recommended by the US Food and Drug Administration (FDA) and the European Agency for the Evaluation of the Medicinal Products (EMEA) in order to obtain a claim, to differentiate a product or to communicate about a product. This therefore requires reliable and validated tools developed following a rigorous methodology (16)(17)(18) .…”
mentioning
confidence: 99%
“…19 One hundred subjects who were currently employed and complaining of a health problem that in their opinion affected their performance at work and/or outside of work were included as participants in the survey.…”
Section: Evaluation Of the Evaluation Of The Psychometric Propertiesmentioning
confidence: 99%